Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × UNKNOWN × Observational × Clear all

Status

Unknown 23 Completed 9 Withdrawn 1 Terminated 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

OTHER 212 INDUSTRY 25 OTHER_GOV 16 NIH 13 NETWORK 2 UNKNOWN 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04491721 2020-07-29

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

ChineseAMS

Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡